Blood pressure breakthrough? yale tests community health worker model

NCT ID NCT06122246

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This Yale study tests two ways to help people with high blood pressure: a remote monitoring program alone, or that program plus a community health worker who helps with home monitoring, appointments, and social needs like food or housing. 1,440 participants with elevated blood pressure will be followed for 18 months to see which approach works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Community Health Worker support and Remote Blood Pressure Management program
What this could lead to
If successful, this could show that adding community health worker support to remote blood pressure management helps more people get their blood pressure under control.
What could go wrong
This is a behavioral study, not a drug trial. Results depend on participant engagement and may not apply to all populations. Blood pressure control can be challenging to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Houston Methodist

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • Massachusetts General Brigham Hospital

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02199, United States

  • Sentara Health

    RECRUITING

    Norfolk, Virginia, 23502, United States

  • Yale

    RECRUITING

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.